September 2025 Preview iPSC lines in development
Read Flipbook
In partnership with the iPSC Neurodegenerative Disease Initiative, a project from the Center for Alzheimer’s and Related Dementias (NIH), and with support from the Chan Zuckerberg Initiative, The Jackson Laboratory now offers a catalog of human induced pluripotent stem cells (iPSCs) for Alzheimer’s and Related Dementias (ADRDs), ALS, and other neurodegenerative disorders.
Read Flipbook
In this webinar, Dr. Oliveira will introduce JAX’s new Tet-inducible neuron and microglia human induced pluripotent stem cell (hiPSCs) lines.
Watch Video
In the field of stem cell research, the quest to define a “reference” induced pluripotent stem cell (iPSC) line is ongoing and nuanced. As we deepen our understanding of human biology, one thing...
Learn More
During this JAX Tech Talk, Dr. Steven Rodriguez, Lab Head of the Rare & Neurological Diseases Therapeutic Area at Sanofi, discusses how his group uses iPSC models to understand disease biology.
Watch Video
Dr. Mark Cookson talks about the unique aspects of the collection of human isogenic iPSC lines and how it can benefit the wider scientific community in their shared quest to understand and fight ADRD.
Watch Video
This webinar is an exclusive behind-the-scenes look at JAX’s precise genetic engineering and high-throughput characterization of our human induced pluripotent stem cell (iPSC) lines.
Watch Video
Induced pluripotent stem cells (iPSCs) have become indispensable tools in modern biomedical research and are transforming how we model human disease, discover drugs, and explore regenerative...
Learn More